GlassScriptPhysician profile
Heidi R Bruty
NPI 1902952054
$3,844.08
in general payments reported to CMS, 2019-2025
15 companies · $1,291 in 2025
The $1,291 reported for 2025 was more than what 84% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $115 · 2021: $312 · 2022: $266 · 2023: $575 · 2024: $998 · 2025: $1,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,863.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $892.26 | 2021-2025 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $532.93 | 2022-2025 | Rexulti, Abilify Maintena |
| Tris Pharma INC | $523.54 | 2019-2025 | Onyda Xr, Dyanavel Xr |
| Noven Therapeutics, LLC | $398.61 | 2023-2025 | Secuado, Xelstrym |
| Corium, LLC | $380.31 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $287.17 | 2019-2025 | Trintellix |
| Ironshore Pharmaceuticals INC. | $276.44 | 2019-2024 | Jornay Pm |
| Neos Therapeutics, LP | $210.83 | 2019-2023 | Adzenys Xr-Odt |
| Collegium Pharmaceutical, INC. | $98.00 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $68.80 | 2024-2025 | Relexxii |
| Axsome Therapeutics, INC. | $58.22 | 2025 | Auvelity |
| Arbor Pharmaceuticals, INC. | $48.98 | 2019 | |
| Shire North American Group INC | $41.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.43 | 2019 | |
| Adlon Therapeutics L.P. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Bruty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.